−21JPY
−289.73 MJPY
794.62 MJPY
7.35 M
About IMMUNO-BIOLOGICAL LABORATORIES CO
Sector
Industry
Headquarters
Fujioka
Website
Employees (FY)
60
Founded
1982
ISIN
JP3921300004
FIGI
BBG000QWHD67
Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals. The Genetically Modified Silkworm segment sells products using the cocoon of genetically modified silkworm. The Testing segment offers prevention and diagnostic support on top of drug discovery and research support in lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics-related segment develops and manufactures cosmetic products containing Neosilk-Human Collagen I. The company was founded on September 9, 1982 and is headquartered in Fujioka, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4570 is 436 JPY — it has decreased by 3.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange IMMUNO-BIOLOGICAL LABORATORIES CO stocks are traded under the ticker 4570.
IMMUNO-BIOLOGICAL LABORATORIES CO is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4570 stock is 5.36% volatile and has beta coefficient of −0.12. Check out the list of the most volatile stocks — is IMMUNO-BIOLOGICAL LABORATORIES CO there?
Yes, you can track IMMUNO-BIOLOGICAL LABORATORIES CO financials in yearly and quarterly reports right on TradingView.
4570 stock has fallen by 11.20% compared to the previous week, the month change is a 19.26% fall, over the last year IMMUNO-BIOLOGICAL LABORATORIES CO has showed a 0.93% increase.
4570 net income for the last quarter is −6.27 M JPY, while the quarter before that showed 15.70 M JPY of net income which accounts for −139.97% change. Track more IMMUNO-BIOLOGICAL LABORATORIES CO financial stats to get the full picture.
Today IMMUNO-BIOLOGICAL LABORATORIES CO has the market capitalization of 4.21 B, it has decreased by 1.83% over the last week.
No, 4570 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4570 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUNO-BIOLOGICAL LABORATORIES CO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 60.00 employees. See our rating of the largest employees — is IMMUNO-BIOLOGICAL LABORATORIES CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMUNO-BIOLOGICAL LABORATORIES CO technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMUNO-BIOLOGICAL LABORATORIES CO stock shows the sell signal. See more of IMMUNO-BIOLOGICAL LABORATORIES CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.